Your device isn't reaching the UK private hospital sector, and that's costing you margin

The UK independent acute hospital market is now worth billions and growing. Private hospitals procure faster than the NHS and at higher margins, yet most MedTech sales teams are structured entirely around NHS pathways.

step: 1; step

1 step

Do it yourself: step by step

0 of 1 done

Develop a private hospital go-to-market track. Identify the top 20 private hospitals in your specialty. Engage directly with clinical directors and theatre managers. Position on consultant preference and patient experience rather than cost-effectiveness.

This problem is Solvable.

Free personal check

Done by Paul Robinson, not software

I'll look at your private hospital plan and show you where to start and who to talk to

What I need from you

Answers to 7 tap questions
Your company website

What you get

Whether your target list is built on real private volume
The approval route you are missing
How your message should change for private buyers

Within 2 working days

No sign-in, no sales call. I read every request myself and reply on WhatsApp.

UK private hospitals - HCA, Spire, Nuffield, Circle - make procurement decisions faster than the NHS and at higher margins. Many MedTech companies ignore this channel because their sales team is NHS-trained. The private sector requires a different value proposition: patient outcomes, consultant preference, and premium positioning.

MedTech companies often have an NHS-centric sales culture and training, leading to a lack of understanding of the private healthcare procurement landscape.
This is compounded by the perception that the NHS represents the entire UK market, overlooking the faster decision-making and higher margins available in the private sector.
Systemically, the differing value propositions (cost-effectiveness for NHS vs.
patient outcomes/consultant preference for private) create a barrier to entry for companies not adapted to this distinction.

The UK independent acute hospital market, including NHS Private Patient Units, crossed £8 billion in 2024, representing a significant addressable market for MedTech companies. (LaingBuisson, 2025)

Inefficient resource allocation towards NHS-only sales channels
Lack of tailored sales and marketing strategies for private providers
Lost revenue from untapped market segments
Reduced market share against competitors focusing on private sector
Perception as an NHS-only supplier, limiting brand appeal to private providers
Missed opportunities to build relationships with key private healthcare opinion leaders

What it looks like in practice

MedTech sales teams exclusively targeting NHS trusts and procurement frameworks
Marketing materials focused on cost-effectiveness and population health outcomes
Limited or no engagement with private hospital clinical directors or theatre managers
Absence from private healthcare industry events and conferences

Paul Robinson

14 years in UK private healthcare

I solve this one for healthcare companies

Want a hand? I'll look at your situation and tell you the three things I'd tackle first.

A few quick questions, about two minutes. I read every one myself and usually reply the same day.

No sales call unless you ask for one. Just a straight answer from me.

I reply personally, usually the same day.

The Solvable community

You're not the only one with this problem.

One problem solved every week, on WhatsApp.

Join the community

One message a week. No sales messages. Reply STOP any time.

Do it yourself: step by step

1Step 1

I'll look at your private hospital plan and show you where to start and who to talk to

What I need from you

What you get

Why this keeps happening

What it leads to

Evidence

Want a hand? I'll look at your situation and tell you the three things I'd tackle first.

You're not the only one with this problem.